BCM
KYMR icon

Boxer Capital Management’s Kymera Therapeutics KYMR Stock Holding History

Boxer Capital Management’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.2M Buy
429,100
+100,000
+30% +$8.59M 3.71% 6
2026
Q1 		$27.4M Hold
329,100
– – 3.6% 4
2025
Q4 		$25.6M Buy
329,100
+10,000
+3% +$675K 5.6% 4
2025
Q3 		$18.1M Sell
319,100
-112,910
-26% -$5.09M 5.76% 4
2025
Q2 		$18.9M Buy
432,010
+107,010
+33% +$3.68M 9.49% 5
2025
Q1 		$8.9M Sell
325,000
-100,000
-24% -$3.65M 2.68% 14
2024
Q4 		$17.1M Buy
+425,000
New +$19.2M 1.46% 22

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Boxer Capital Management's KYMR Position: Q2 2026 in Review

Boxer Capital Management increased its Kymera Therapeutics (KYMR) stake by 30% in Q2 2026, buying an estimated $8.59M and bringing the position to 429,100 shares worth $49.2M. The position accounts for 3.71% of the portfolio, ranked #6.

Boxer Capital Management first reported a position in KYMR in Q4 2024 and has held it in 7 quarters since. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Boxer Capital Management held 429,100 shares of Kymera Therapeutics worth $49.2M as of Q2 2026.
  • Boxer Capital Management bought 100,000 Kymera Therapeutics shares in Q2 2026, an estimated $8.59M.
  • Kymera Therapeutics made up 3.71% of Boxer Capital Management's portfolio in Q2 2026, its #6 holding.
  • Boxer Capital Management first reported a position in Kymera Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Boxer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.